Analyst Gregory Fraser works at TRUIST and is focused on the Healthcare sector with 59 price targets and ratings documented since 2019 spanning on 10 stocks. Analyst's average stock valuation to be materialised ratio is 30.5% with an average time for price targets to be met of 82.7 days.
Most recent stock forecast was given on NVCR, NovoCure Limited at 28-Oct-2022.
Gregory Fraser best performing recommendations are on EOLS (EVOLUS, INC).
The best stock recommendation documented was for EOLS (EVOLUS, INC) at 2/24/2021. The price target of $12 was fulfilled within 2 days with a profit of $0.54 (4.71%) receiving and performance score of 23.56.
Average potential price target upside
Currently, out of the existing stock ratings of Gregory Fraser - 2431 which are a Buy (78.19%), 678 which are a Hold (21.81%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Buy
12
11 months 16 days ago
0/1 (0%)
$3.91 (48.33%)
Buy
10
$9.98 (49900.00%)
1 years 5 months 13 days ago
0/1 (0%)
$4.78 (91.57%)
